184 related articles for article (PubMed ID: 25044099)
1. The clopidogrel conundrum.
Bertino JS
J Clin Pharmacol; 2014 Aug; 54(8):841-2. PubMed ID: 25044099
[No Abstract] [Full Text] [Related]
2. Clopidogrel, CYP2C19 and proton pump inhibitors: what we know and what it means.
Hariharan S; Southworth MR; Madabushi R
J Clin Pharmacol; 2014 Aug; 54(8):884-8. PubMed ID: 25044100
[No Abstract] [Full Text] [Related]
3. Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity.
Harvey A; Modak A; Déry U; Roy M; Rinfret S; Bertrand OF; Larose É; Rodés-Cabau J; Barbeau G; Gleeton O; Nguyen CM; Proulx G; Noël B; Roy L; Paradis JM; De Larochellière R; Déry JP
J Breath Res; 2016 Jan; 10(1):017104. PubMed ID: 26815196
[TBL] [Abstract][Full Text] [Related]
4. [Clinically relevant interaction between clopidogrel and proton pump inhibitors].
Alban S; Dingermann T; Griese N; Kämmerer W; Schubert-Zsilavecz M; Schulz M; Trenk D; Zagermann-Muncke P
Pharm Unserer Zeit; 2009; 38(4):370-1. PubMed ID: 19572357
[No Abstract] [Full Text] [Related]
5. Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis.
Hsu PI; Lai KH; Liu CP
Gastroenterology; 2011 Mar; 140(3):791-8. PubMed ID: 21144850
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole, pantoprazole, and CYP2C19 effects on clopidogrel pharmacokinetic-pharmacodynamic relationships in stable coronary artery disease patients.
Simon N; Finzi J; Cayla G; Montalescot G; Collet JP; Hulot JS
Eur J Clin Pharmacol; 2015 Sep; 71(9):1059-66. PubMed ID: 26071277
[TBL] [Abstract][Full Text] [Related]
7. Drug interaction: Clopidogrel and PPIs.
Med Lett Drugs Ther; 2017 Feb; 59(1515):39-40. PubMed ID: 28222065
[No Abstract] [Full Text] [Related]
8. Impact of esomeprazole on platelet reactivity and clinical outcome according to CYP2C19 genotype in coronary heart disease patients during dual antiplatelet therapy.
Hokimoto S; Akasaka T; Tabata N; Arima Y; Tsujita K; Sakamoto K; Kaikita K; Morita K; Kumagae N; Yamamoto E; Oniki K; Nakagawa K; Ogawa H
Thromb Res; 2015 Jun; 135(6):1081-6. PubMed ID: 25891840
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors and clopidogrel.
Gaglia MA; Waksman R
Cardiovasc Ther; 2010 Jun; 28(3):169-76. PubMed ID: 20345494
[TBL] [Abstract][Full Text] [Related]
10. Omeprazole: a possible new candidate influencing the antiplatelet effect of clopidogrel.
Gurbel PA; Lau WC; Tantry US
J Am Coll Cardiol; 2008 Jan; 51(3):261-3. PubMed ID: 18206733
[No Abstract] [Full Text] [Related]
11. The clopidogrel-statin interaction.
Tantry US; Jeong YH; Gurbel PA
Circ J; 2014; 78(3):592-4. PubMed ID: 24521731
[No Abstract] [Full Text] [Related]
12. Proton pump inhibitor co-therapy with clopidogrel: is there GI benefit or cardiovascular harm?
Laine L
Gastroenterology; 2011 Mar; 140(3):769-72. PubMed ID: 21266209
[No Abstract] [Full Text] [Related]
13. [Pharmacogenetics of clopidogrel and its clinical significance].
Panchenko EP; Komarov AL
Kardiologiia; 2012; 52(9):44-52. PubMed ID: 23098546
[TBL] [Abstract][Full Text] [Related]
14. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
Sibbing D; Morath T; Stegherr J; Braun S; Vogt W; Hadamitzky M; Schömig A; Kastrati A; von Beckerath N
Thromb Haemost; 2009 Apr; 101(4):714-9. PubMed ID: 19350116
[TBL] [Abstract][Full Text] [Related]
15. Nonresponders to clopidogrel: pharmacokinetics and interactions involved.
Giorgi MA; Di Girolamo G; González CD
Expert Opin Pharmacother; 2010 Oct; 11(14):2391-403. PubMed ID: 20828266
[TBL] [Abstract][Full Text] [Related]
16. Clopidogrel: what is a cardiologist to do?
Ford NF
J Clin Pharmacol; 2014 Aug; 54(8):881-3. PubMed ID: 24824921
[No Abstract] [Full Text] [Related]
17. [Safety and effectiveness of combining clopidogrel and proton pump inhibitors].
Calderón Hernanz B; Pinteño Blanco M; Puigventos Latorre F; Martínez-López I
Farm Hosp; 2009; 33(6):338-9. PubMed ID: 20038395
[No Abstract] [Full Text] [Related]
18. CYP2C19 genotype and proton pump inhibitors in clopidogrel-treated patients: does it take two to tango?
O'Donoghue ML
Circulation; 2011 Feb; 123(5):468-70. PubMed ID: 21262991
[No Abstract] [Full Text] [Related]
19. [Interaction between clopidogrel and proton pump inhibitors].
Harmsze AM; de Boer A; Boot H; Deneer VH; Heringa M; Mol PG; Schalekamp T; Verduijn MM; Verheugt FW; le Comte M
Ned Tijdschr Geneeskd; 2011; 155(28):A2442. PubMed ID: 21771377
[TBL] [Abstract][Full Text] [Related]
20. Clopidogrel and Genotyping.
Ford NF
J Invasive Cardiol; 2015 Aug; 27(8):E173-4. PubMed ID: 26232022
[No Abstract] [Full Text] [Related]
[Next] [New Search]
